Home

Explore NIH Technologies

Explore work by over 1,500 NIH researchers   |   Available for Licensing & Collaboration

 
MedInvest is hosting a Biotech and Pharma Investor Conference March 31-April 1, 2026 in New York City. NIH’s Steve Ferguson and Michael Salgaller will be speaking. They will be discussing NIH as a premier technology transfer partner, how the process at the NIH works, and answering questions! This is
Currently, there is no effective treatment for many types of retinal degeneration. Nor are there sufficient treatments for autoimmune uveitis, as current uveitis treatment primarily uses steroidal anti-inflammatory medication, which can produce significant unwanted side effects with long-term use
NIH inventors have developed an image-based machine learning system that is able to validate functional cell phenotypes. The system may be trained to automatically recognize image features that correlate with a desired cell-type or properties for research, diagnostic, and therapeutic purposes. This

Explore Featured Research

Get updates on the latest and most exciting research coming out of NIH...

Read More >

Explore Featured Products

Novel and interesting products coming to market through NIH inventions and partnerships...

Read More >